Quarry LP Cytokinetics Inc Transaction History
Quarry LP
- $398 Billion
- Q3 2024
A detailed history of Quarry LP transactions in Cytokinetics Inc stock. As of the latest transaction made, Quarry LP holds 3,000 shares of CYTK stock, worth $143,010. This represents 0.04% of its overall portfolio holdings.
Number of Shares
3,000
Previous 2,000
50.0%
Holding current value
$143,010
Previous $108 Million
46.18%
% of portfolio
0.04%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding CYTK
# of Institutions
410Shares Held
125MCall Options Held
4.6MPut Options Held
2.43M-
Black Rock Inc. New York, NY14.7MShares$699 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$561 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.69MShares$462 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA7.77MShares$371 Million0.07% of portfolio
-
State Street Corp Boston, MA6.46MShares$308 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.49B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...